vs
通用电气医疗（GEHC）与维萨（V）财务数据对比。点击上方公司名可切换其他公司
维萨的季度营收约是通用电气医疗的2.0倍（$11.2B vs $5.7B），维萨净利率更高（53.4% vs 10.3%，领先43.1%），维萨同比增速更快（17.0% vs 7.1%），过去两年维萨的营收复合增速更高（12.3% vs 10.7%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
维萨（Visa Inc.）是总部位于美国加利福尼亚州旧金山的跨国支付卡服务企业，业务覆盖全球电子资金转账领域，旗下拥有Visa品牌的信用卡、借记卡、预付卡等多条产品线，为全球消费者及商户提供安全便捷的电子支付解决方案。
GEHC vs V — 直观对比
营收规模更大
V
是对方的2.0倍
$5.7B
营收增速更快
V
高出9.9%
7.1%
净利率更高
V
高出43.1%
10.3%
两年增速更快
V
近两年复合增速
10.7%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.7B | $11.2B |
| 净利润 | $588.0M | $6.0B |
| 毛利率 | 39.7% | — |
| 营业利润率 | 14.5% | 64.4% |
| 净利率 | 10.3% | 53.4% |
| 营收同比 | 7.1% | 17.0% |
| 净利润同比 | -18.4% | 32.0% |
| 每股收益（稀释后） | $1.28 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GEHCV
| Q2 26 | — | $11.2B | ||
| Q4 25 | $5.7B | $10.9B | ||
| Q3 25 | $5.1B | $10.7B | ||
| Q2 25 | $5.0B | $10.2B | ||
| Q1 25 | $4.8B | $9.6B | ||
| Q4 24 | $5.3B | $9.5B | ||
| Q3 24 | $4.9B | $9.6B | ||
| Q2 24 | $4.8B | $8.9B |
净利润GEHCV
| Q2 26 | — | $6.0B | ||
| Q4 25 | $588.0M | $5.9B | ||
| Q3 25 | $446.0M | $5.1B | ||
| Q2 25 | $486.0M | $5.3B | ||
| Q1 25 | $564.0M | $4.6B | ||
| Q4 24 | $721.0M | $5.1B | ||
| Q3 24 | $470.0M | $5.3B | ||
| Q2 24 | $428.0M | $4.9B |
毛利率GEHCV
| Q2 26 | — | — | ||
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — |
营业利润率GEHCV
| Q2 26 | — | 64.4% | ||
| Q4 25 | 14.5% | 61.8% | ||
| Q3 25 | 12.7% | 57.3% | ||
| Q2 25 | 13.1% | 60.7% | ||
| Q1 25 | 13.2% | 56.6% | ||
| Q4 24 | 15.1% | 65.6% | ||
| Q3 24 | 13.9% | 66.0% | ||
| Q2 24 | 12.6% | 66.7% |
净利率GEHCV
| Q2 26 | — | 53.4% | ||
| Q4 25 | 10.3% | 53.7% | ||
| Q3 25 | 8.7% | 47.5% | ||
| Q2 25 | 9.7% | 51.8% | ||
| Q1 25 | 11.8% | 47.7% | ||
| Q4 24 | 13.6% | 53.8% | ||
| Q3 24 | 9.7% | 55.3% | ||
| Q2 24 | 8.8% | 54.7% |
每股收益（稀释后）GEHCV
| Q2 26 | — | — | ||
| Q4 25 | $1.28 | — | ||
| Q3 25 | $0.98 | — | ||
| Q2 25 | $1.06 | — | ||
| Q1 25 | $1.23 | — | ||
| Q4 24 | $1.58 | — | ||
| Q3 24 | $1.02 | — | ||
| Q2 24 | $0.93 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $12.4B |
| 总债务越低越好 | $10.0B | $22.4B |
| 股东权益账面价值 | $10.4B | $35.7B |
| 总资产 | $36.9B | $95.0B |
| 负债/权益比越低杠杆越低 | 0.96× | 0.63× |
8季度趋势，按日历期对齐
现金及短期投资GEHCV
| Q2 26 | — | $12.4B | ||
| Q4 25 | $4.5B | $14.8B | ||
| Q3 25 | $4.0B | $17.2B | ||
| Q2 25 | $3.7B | $17.1B | ||
| Q1 25 | $2.5B | $11.7B | ||
| Q4 24 | $2.9B | $12.4B | ||
| Q3 24 | $3.5B | $12.0B | ||
| Q2 24 | $2.0B | $12.9B |
总债务GEHCV
| Q2 26 | — | $22.4B | ||
| Q4 25 | $10.0B | — | ||
| Q3 25 | $10.3B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $9.0B | — | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.2B | — |
股东权益GEHCV
| Q2 26 | — | $35.7B | ||
| Q4 25 | $10.4B | $38.8B | ||
| Q3 25 | $10.0B | $37.9B | ||
| Q2 25 | $9.7B | $38.7B | ||
| Q1 25 | $9.2B | $38.0B | ||
| Q4 24 | $8.4B | $38.3B | ||
| Q3 24 | $8.3B | $39.1B | ||
| Q2 24 | $7.8B | $39.7B |
总资产GEHCV
| Q2 26 | — | $95.0B | ||
| Q4 25 | $36.9B | $96.8B | ||
| Q3 25 | $36.1B | $99.6B | ||
| Q2 25 | $35.5B | $100.0B | ||
| Q1 25 | $33.6B | $92.9B | ||
| Q4 24 | $33.1B | $91.9B | ||
| Q3 24 | $33.9B | $94.5B | ||
| Q2 24 | $31.9B | $91.0B |
负债/权益比GEHCV
| Q2 26 | — | 0.63× | ||
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
V
| Data processing revenue | $5.5B | 49% |
| International transaction revenue | $3.6B | 32% |
| Other revenue | $1.3B | 12% |
| Other | $736.0M | 7% |
